NOCIL Surges Nearly 20% as Anti-Dumping Duty Safeguards Domestic Rubber Chemical Market
Regulatory Action Drives Major Rally in NOCIL Shares
NOCIL shares experienced a substantial surge, climbing nearly 19.64 percent on Monday. The stock, which was trading at ₹190.25, rocketed to become one of the top gainers across exchanges. This significant rally is directly attributed to the government's imposition of anti-dumping duties on imported Sulphenamides Accelerators.The move came after the Directorate General of Trade Remedies (DGTR) announced these protective duties. The action targets imports of this crucial rubber chemical from China, the United States, and the European Union. These duties will remain in effect for a period of five years. This regulatory intervention is specifically aimed at fortifying and protecting domestic manufacturers within the sector.
Significance of Anti-Dumping Duty on Rubber Chemicals
The anti-dumping duty mechanism seeks to shield local producers from heavily subsidized or cheaper imports. The targeted Sulphenamides Accelerators are vital inputs for the rubber and tyre industry. These chemicals are widely used in the vulcanisation process, making them critical components in tyre production.For NOCIL, this regulatory relief is extremely important. As India's largest producer of these chemical compounds, NOCIL manufactures a range of Sulphenamide Accelerators under its brand name, Pilcure. The imposition of the duty is anticipated to enhance pricing power and significantly improve market share for domestic players like NOCIL.
Shareholding Pattern and Broker Sentiment for NOCIL
Analyzing the company's structure reveals a concentrated promoter holding. In the March-quarter shareholding pattern, promoters maintained a 33.76 percent stake in NOCIL. Domestic mutual funds held a 7.1 percent stake of the stock. Retail investors account for a significant portion at 26.2 percent, while foreign portfolio investors hold 4.5 percent.Analyst sentiment covering the stock remains varied. Out of the seven analysts who currently cover NOCIL, three maintain a "Buy" rating. Three other analysts recommend "Hold." Finally, one analyst maintains a "Sell" recommendation, indicating a mixed outlook for stakeholders.
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.